Showing results (1921-1930 of 4,356) with videos related to

Sort By:
Pageof 436
Journal of Thoracic Disease|March 20, 2024
A closed surgical intensive care unit organization improves cardiac surgical patient outcomesLauren A Johnson, Brianna Klucher, Hanna Jensen, et al.
Molecular Pharmacology|March 8, 2024
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide AgonistsPeter Keov, George Christopoulos, Caroline A Hick, et al.
The Medical Journal of Australia|December 27, 2023
Socio-economic status and access to fluoridated water in Queensland: an ecological data linkage studyChristopher T Sexton, Diep H Ha, Thu Le, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 3, 2022
In Vivo Models for Studying Interstitial Photodynamic Therapy of Locally Advanced CancerGal Shafirstein, Emily Oakley, Sasheen Hamilton, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2010
Modulation of the glucagon-like peptide-1 receptor signaling by naturally occurring and synthetic flavonoidsDenise Wootten, John Simms, Cassandra Koole, et al.
Inhalation Toxicology|June 19, 2004
Photochemical products in urban mixtures enhance inflammatory responses in lung cellsKenneth G Sexton, Harvey E Jeffries, Myoseon Jang, et al.
Molecular Pharmacology|May 10, 2008
Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist bindingMaoqing Dong, Polo C-H Lam, Delia I Pinon, et al.
JTCVS Open|May 1, 2025
Preclinical experience with cisplatin, gemcitabine, and doxorubicin in pulmonary suffusionLindsay J Nitsche, Leslie Curtin, Sandra Sexton, et al.
AJR. American Journal of Roentgenology|May 25, 2013
Implementation of breast tomosynthesis in a routine screening practice: an observational studyStephen L Rose, Andra L Tidwell, Louis J Bujnoch, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Randomized, double-blind trial of cefonicid and nafcillin in the treatment of skin and skin structure infectionsJ S Daly, M G Worthington, R J Andrews, et al.
Pageof 436